These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 3828839
1. Chronic haloperidol decreases dopamine release in striatum and nucleus accumbens in vivo: depolarization block as a possible mechanism of action. Lane RF, Blaha CD. Brain Res Bull; 1987 Jan; 18(1):135-8. PubMed ID: 3828839 [Abstract] [Full Text] [Related]
2. Chronic treatment with classical and atypical antipsychotic drugs differentially decreases dopamine release in striatum and nucleus accumbens in vivo. Blaha CD, Lane RF. Neurosci Lett; 1987 Jul 22; 78(2):199-204. PubMed ID: 2888060 [Abstract] [Full Text] [Related]
3. Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment. Ichikawa J, Meltzer HY. Brain Res; 1990 Jan 15; 507(1):138-42. PubMed ID: 2302571 [Abstract] [Full Text] [Related]
4. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens. Compton DR, Johnson KM. J Pharmacol Exp Ther; 1989 Feb 15; 248(2):521-30. PubMed ID: 2918468 [Abstract] [Full Text] [Related]
5. Acute thioridazine stimulates mesolimbic but not nigrostriatal dopamine release: demonstration by in vivo electrochemistry. Lane RF, Blaha CD. Brain Res; 1987 Apr 07; 408(1-2):317-20. PubMed ID: 2439169 [Abstract] [Full Text] [Related]
6. Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens. Ichikawa J, Meltzer HY. J Pharmacol Exp Ther; 1991 Jan 07; 256(1):348-57. PubMed ID: 1703232 [Abstract] [Full Text] [Related]
7. The effect of chronic clozapine and haloperidol on basal dopamine release and metabolism in rat striatum and nucleus accumbens studied by in vivo microdialysis. Ichikawa J, Meltzer HY. Eur J Pharmacol; 1990 Feb 13; 176(3):371-4. PubMed ID: 2184042 [Abstract] [Full Text] [Related]
8. The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo. Ichikawa J, Meltzer HY. Brain Res; 1992 Mar 06; 574(1-2):98-104. PubMed ID: 1379112 [Abstract] [Full Text] [Related]
9. Haloperidol given chronically decreases basal dopamine in the prefrontal cortex more than the striatum or nucleus accumbens as simultaneously measured by microdialysis. Hernandez L, Hoebel BG. Brain Res Bull; 1989 Apr 06; 22(4):763-9. PubMed ID: 2736403 [Abstract] [Full Text] [Related]
11. The contrasting effects of neuroleptics on transmitter release from the nucleus accumbens and corpus striatum. de Belleroche JS, Neal MJ. Neuropharmacology; 1982 Jun 06; 21(6):529-37. PubMed ID: 6125910 [Abstract] [Full Text] [Related]
12. Selective inhibition of mesolimbic dopamine release following chronic administration of clozapine: involvement of alpha 1-noradrenergic receptors demonstrated by in vivo voltammetry. Lane RF, Blaha CD, Rivet JM. Brain Res; 1988 Sep 20; 460(2):398-401. PubMed ID: 2852047 [Abstract] [Full Text] [Related]
13. The importance of dopaminergic neurotransmission in the hypermotility response produced by the administration of N-methyl-D-aspartic acid into the nucleus accumbens. Boldry RC, Uretsky NJ. Neuropharmacology; 1988 Jun 20; 27(6):569-77. PubMed ID: 2901677 [Abstract] [Full Text] [Related]
14. In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbens. Lane RF, Blaha CD, Phillips AG. Brain Res; 1986 Nov 05; 397(1):200-4. PubMed ID: 3801862 [Abstract] [Full Text] [Related]
15. Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol. Memo M, Pizzi M, Missale C, Carruba MO, Spano PF. Neuropharmacology; 1987 May 05; 26(5):477-80. PubMed ID: 2955241 [Abstract] [Full Text] [Related]
16. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain. Wilmot CA, Szczepanik AM. Brain Res; 1989 May 22; 487(2):288-98. PubMed ID: 2525063 [Abstract] [Full Text] [Related]
17. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. Karoum F, Chrapusta SJ, Egan MF. J Neurochem; 1994 Sep 22; 63(3):972-9. PubMed ID: 7914228 [Abstract] [Full Text] [Related]
18. Ethanol enhances the calcium-dependent stimulus-induced release of endogenous dopamine from slices of rat striatum and nucleus accumbens in vitro. Snape BM, Engel JA. Neuropharmacology; 1988 Nov 22; 27(11):1097-101. PubMed ID: 3205382 [Abstract] [Full Text] [Related]
19. In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum. Navailles S, De Deurwaerdère P, Porras G, Spampinato U. Neuropsychopharmacology; 2004 Feb 22; 29(2):319-26. PubMed ID: 14560323 [Abstract] [Full Text] [Related]
20. Apomorphine decreases stimulated dopamine release in rat nucleus accumbens but not in neostriatum: in vivo voltammetric data. Stamford JA, Kruk ZL, Millar J. Eur J Pharmacol; 1987 Jul 23; 139(3):363-4. PubMed ID: 3666014 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]